Should NZ grow genetically modified crops?
What are the benefits, if any? And is it inevitable? Two views from opposite sides of the argument from Agram chief executive Graeme Peters and university researcher Professor Jack Heinemann.
AdvertisementAdvertise with NZME.
Latest fromBiotechnology
The singular vision of Peter Thiel
Why is this internet billionaire so keen on New Zealand? And why are we handing him taxpayers' money to invest? Chris Barton reports.
China Business 2012: Clearing the path for cleantech
Securing even a small slice of China's cleantech future will be a boon for Kiwi companies writes Ellen Read
GE law probe a big surprise
Minister 'unaware' of questions on genetic engineering gains.
NZ diabetes company rescued by Japanese cash
The New Zealand maker of a revolutionary diabetes therapy, Living Cell Technologies, has been rescued from closure by a $32.1m Japanese injection.
Success: Down to earth focus earns growing revenue
Research and development business specialises in NZ's key crop - grass.
Rebuilding Christchurch business: Canterbury Scientific
Canterbury Scientific Limited opened the doors to its new $1.2 million laboratory complex in Addington a few days before February's devastating earthquake.
Anthony Doesburg: Broking a marriage of business and academia
Events aim to encourage university researchers and companies to start talking to each other.
More to be done on tax, education, says Treasury secretary
More can be done to improve the tax system to promote economic growth, says Treasury secretary John Whitehead.
Tools measure impact of cancer drugs
The next breakthrough in cancer treatment drugs could be helped by Timaru biotech company Symansis.
'Cat on a sofa' stemcell breakthrough
Australian scientists have found a unique way to grow a precious and life-saving type of stem cell, likened to putting a "cat on a sofa", in the lab.